Here is how I see it: the reported neoplasms (abnormal growths) in 3% of the patients in the stud is enough and of the 23 neoplasms with the 9 tested malignant in the treatment group and 2 in the placebo group is significant enough to potentially warrant it mute.
These statistics weigh against ANP today.
I will argue that the trading halt will be backed by an announcement trying to stop the rot.
Will be interesting to see what ANP has to say.
Here is how I see it: the reported neoplasms (abnormal growths)...
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
